Advertisement
Screener

Voyager Therapeutics, Inc. (VYGR) Other

Voyager Therapeutics, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-09: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market.
  • 2026-03-09: Form 10-K; Item Smaller reporting company; As filed No.
  • 2025-11-10: Form 10-Q; Item Smaller reporting company; As filed No.
  • 2025-08-06: Form 10-Q; Item Smaller reporting company; As filed No.
FiledFormItemAs filed
2026-03-0910-KStock registered under Section 12(b)Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market
2026-03-0910-KSmaller reporting companyNo
2025-11-1010-QSmaller reporting companyNo
2025-08-0610-QSmaller reporting companyNo
2025-05-0610-QSmaller reporting companyNo
2025-03-1110-KStock registered under Section 12(b)Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market
2025-03-1110-KSmaller reporting companyNo
2024-02-2810-KStock registered under Section 12(b)Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market
2023-03-0710-KStock registered under Section 12(b)Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market
2022-05-0410-QStock registered under Section 12(b)Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market
2022-03-0810-KStock registered under Section 12(b)Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market
2021-11-0210-QSmaller reporting companyNo
2021-08-0910-QSmaller reporting companyNo
2021-05-1010-QStock registered under Section 12(b)Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market
2021-05-1010-QSmaller reporting companyNo
2021-02-2510-KStock registered under Section 12(b)Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market
2020-11-0910-QEmerging growth companyYes
2020-08-1010-QEmerging growth companyYes
2020-05-0610-QStock registered under Section 12(b)Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market
2020-05-0610-QEmerging growth companyYes
2020-03-0310-KStock registered under Section 12(b)Common Stock, $0.001 par value · VYGR · Nasdaq Global Select Market
2020-03-0310-KEmerging growth companyYes
2019-11-0610-QEmerging growth companyYes
2019-08-0910-QEmerging growth companyYes
2019-05-0710-QEmerging growth companyYes
2019-02-2610-KEmerging growth companyYes
2018-11-0710-QEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79